Coronavirus: Bharat Biotech gets approval for clinical trials of Covaxin on children aged 2-18

Scroll Staff

· May 13, 2021 · 12:31 pm

Coronavirus: No Covaxin shot for 18 to 44 age group in Delhi from Thursday

Scroll Staff

· May 12, 2021 · 07:50 pm

As Indian government offers some answers on Covaxin patent rights, more questions emerge

R Ramakumar

· May 12, 2021 · 07:45 pm

Coronavirus: 18 states getting direct supply of Covaxin since May 1, says Bharat Biotech

Scroll Staff

· May 12, 2021 · 08:19 am

Covid-19: Covaxin price reduced to Rs 400 per dose from Rs 600 for states

Scroll Staff

· Apr 29, 2021 · 08:52 pm

Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer

R Ramakumar

· Apr 26, 2021 · 06:30 am

Coronavirus: Covaxin priced at Rs 1,200 for private companies, Rs 600 for states

Scroll Staff

· Apr 25, 2021 · 07:52 am

Coronavirus: Covaxin shows 78% efficacy in phase 3 interim analysis, says Bharat Biotech

Scroll Staff

· Apr 21, 2021 · 09:49 pm

Covishield vaccine to cost Rs 400 per dose for states, Rs 600 for private hospitals: Serum Institute

Scroll Staff

· Apr 21, 2021 · 01:16 pm

Coronavirus: Covaxin neutralises double mutant strain, other variants, says ICMR

Scroll Staff

· Apr 21, 2021 · 09:35 am

India’s decision to liberalise vaccine sales likely to push up prices – and block access to millions

R Ramakumar

· Apr 20, 2021 · 09:17 am

Coronavirus: Haffkine Biopharma to produce Covaxin after Centre grants approval to Maharashtra

Scroll Staff

· Apr 16, 2021 · 08:08 am

Coronavirus: 320 doses of Covaxin missing from Jaipur hospital, FIR filed

Scroll Staff

· Apr 14, 2021 · 08:13 pm

Coronavirus: Centre’s expert panel allows clinical trials of third dose of Covaxin

Scroll Staff

· Apr 02, 2021 · 02:46 pm

Coronavirus: Bharat Biotech, AstraZeneca studying vaccine shots for children, says AIIMS chief

Scroll Staff

· Apr 01, 2021 · 12:04 pm

Brazil refuses permission to import Covaxin, Bharat Biotech says it will fulfil requirements

Scroll Staff

· Mar 31, 2021 · 08:38 pm

Coronavirus: SC stays cases before High Courts on petitions seeking priority vaccination for lawyers

Scroll Staff

· Mar 18, 2021 · 04:05 pm

Bharat Biotech’s Covaxin can drop ‘clinical trial mode’ tag, no consent form needed anymore

Scroll Staff

· Mar 11, 2021 · 08:20 am

Covaxin is safe and immunogenic, but cannot determine efficacy by second phase trials: Lancet study

Scroll Staff

· Mar 09, 2021 · 01:02 pm

Disclose your capacity to manufacture Covid vaccines, Delhi HC tells Serum Institute, Bharat Biotech

Scroll Staff

· Mar 04, 2021 · 03:06 pm